EORTC contributes to cancer research by conducting clinical trials that test the efficacy and safety of new treatments. These trials often involve multiple cancer centers across Europe and sometimes beyond, ensuring a diverse patient population and robust data. EORTC's research covers a wide range of cancer types, including rare cancers, making it an invaluable resource in the global fight against cancer. Additionally, EORTC facilitates the translation of scientific discoveries into clinical practice, bridging the gap between laboratory research and patient care.
